A citation-based method for searching scientific literature

Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
Times Cited: 50







List of co-cited articles
363 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
224
44

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
203
42

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
42

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
280
38

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
260
38

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
104
32

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
339
32

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Miriam Potrony, Joan Anton Puig-Butillé, Paula Aguilera, Celia Badenas, Cristina Carrera, Josep Malvehy, Susana Puig. J Am Acad Dermatol 2014
36
44

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
28

Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
Bhramar Mukherjee, John Oliver Delancey, Leon Raskin, Jessica Everett, Joanne Jeter, Colin B Begg, Irene Orlow, Marianne Berwick, Bruce K Armstrong, Anne Kricker,[...]. J Natl Cancer Inst 2012
33
42

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
26

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
613
26

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
118
26

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
249
24

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
283
24

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
24

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
24

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
488
22

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
22

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder,[...]. J Natl Cancer Inst 2010
76
22

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
P Ghiorzo, L Pastorino, P Queirolo, W Bruno, M G Tibiletti, S Nasti, V Andreotti, B Bressac-de Paillerets, G Bianchi Scarrà. Pigment Cell Melanoma Res 2013
65
20


Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
Jasper I van der Rhee, Pieta Krijnen, Nelleke A Gruis, Femke A de Snoo, Hans F A Vasen, Hein Putter, Nicole A Kukutsch, Wilma Bergman. J Am Acad Dermatol 2011
30
33

Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.
Hildur Helgadottir, Veronica Höiom, Rainer Tuominen, Kari Nielsen, Göran Jönsson, Håkan Olsson, Johan Hansson. J Natl Cancer Inst 2016
28
35

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
18

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
18

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
83
18

BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
388
16

Germline mutations in shelterin complex genes are associated with familial glioma.
Matthew N Bainbridge, Georgina N Armstrong, M Monica Gramatges, Alison A Bertuch, Shalini N Jhangiani, Harsha Doddapaneni, Lora Lewis, Joseph Tombrello, Spyros Tsavachidis, Yanhong Liu,[...]. J Natl Cancer Inst 2014
133
16

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
16

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Maria Concetta Fargnoli, Sara Gandini, Ketty Peris, Patrick Maisonneuve, Sara Raimondi. Eur J Cancer 2010
58
16

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
16

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
109
16

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
118
16

Identification, genetic testing, and management of hereditary melanoma.
Sancy A Leachman, Olivia M Lucero, Jone E Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Cancer Metastasis Rev 2017
55
16

Hereditary uveal melanoma: a report of a germline mutation in BAP1.
Veronica Höiom, Daniel Edsgärd, Hildur Helgadottir, Hanna Eriksson, Charlotta All-Ericsson, Rainer Tuominen, Ivayla Ivanova, Joakim Lundeberg, Olof Emanuelsson, Johan Hansson. Genes Chromosomes Cancer 2013
39
17

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
A M Goldstein, J P Struewing, A Chidambaram, M C Fraser, M A Tucker. J Natl Cancer Inst 2000
135
14

MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
Marianne Berwick, Jamie MacArthur, Irene Orlow, Peter Kanetsky, Colin B Begg, Li Luo, Anne Reiner, Ajay Sharma, Bruce K Armstrong, Anne Kricker,[...]. Pigment Cell Melanoma Res 2014
29
24

Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
634
14

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
181
14

A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
K A W Wadt, L G Aoude, P Johansson, A Solinas, A Pritchard, O Crainic, M T Andersen, J F Kiilgaard, S Heegaard, L Sunde,[...]. Clin Genet 2015
66
14


Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
79
14

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.
Thomas P Potjer, Heidi E Kranenburg, Wilma Bergman, Wouter H de Vos tot Nederveen Cappel, Hester S van Monsjou, Daniela Q C M Barge-Schaapveld, Hans F A Vasen. Eur J Hum Genet 2015
20
35

CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Hildur Helgadottir, Veronica Höiom, Rainer Tuominen, Göran Jönsson, Eva Månsson-Brahme, Håkan Olsson, Johan Hansson. Int J Cancer 2015
11
63

Germline TERT promoter mutations are rare in familial melanoma.
Mark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, Zhihao Ding, Nelleke A Gruis, Remco van Doorn, Karen A Pooley, Alison M Dunning, Lauren G Aoude, Karin A W Wadt,[...]. Fam Cancer 2016
28
25

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
N A Gruis, P A van der Velden, L A Sandkuijl, D E Prins, J Weaver-Feldhaus, A Kamb, W Bergman, R R Frants. Nat Genet 1995
277
12

A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma.
Karin Wadt, Jiyeon Choi, Joon-Yong Chung, Jens Kiilgaard, Steffen Heegaard, Krzysztof T Drzewiecki, Jeffrey M Trent, Stephen M Hewitt, Nicholas K Hayward, Anne-Marie Gerdes,[...]. Pigment Cell Melanoma Res 2012
86
12

Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
A de la Fouchardière, O Cabaret, L Savin, P Combemale, H Schvartz, C Penet, V Bonadona, N Soufir, B Bressac-de Paillerets. Clin Genet 2015
68
12

Frequent mutation of BAP1 in metastasizing uveal melanomas.
J William Harbour, Michael D Onken, Elisha D O Roberson, Shenghui Duan, Li Cao, Lori A Worley, M Laurin Council, Katie A Matatall, Cynthia Helms, Anne M Bowcock. Science 2010
894
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.